Dima Kabbani, University of Toronto

Research

Acute Leukemia Allogeneic Hematopoietic Stem Cell Transplant Antibiotic Stewardship Febrile Neutropenia

Latest papers

Granuloma in the explanted lungs: Infectious causes and impact on post-lung transplant mycobacterial infection.
Transplant infectious disease : an official journal of the Transplantation Society · 2020 · first author
Outbreak of invasive aspergillosis in heart transplant recipients: The role of screening computed tomography scans in asymptomatic patients and universal antifungal prophylaxis.
Transplant infectious disease : an official journal of the Transplantation Society · 2018 · first author

All 2 publications

Latest funding

Early discontinuation of antibiotics for unexplained febrile neutropenia: a pilot randomized controlled trial- EASE ANTIBIOTICS pilot trial
CIHR · 2023 · Principal investigator
$512,551

All 1 grants and awards

2 publications.

01

Granuloma in the explanted lungs: Infectious causes and impact on post-lung transplant mycobacterial infection.

Kabbani D, Kozlowski HN, Cervera C, Chaparro C, Singer L, Rotstein C, Keshavjee S, Husain S

Transplant infectious disease : an official journal of the Transplantation Society2020First author

DOI: 10.1111/tid.13262 PMID: 32043708

02

Outbreak of invasive aspergillosis in heart transplant recipients: The role of screening computed tomography scans in asymptomatic patients and universal antifungal prophylaxis.

Kabbani D, Goldraich L, Ross H, Rotstein C, Husain S

Transplant infectious disease : an official journal of the Transplantation Society2018First author

DOI: 10.1111/tid.12808 PMID: 29125713

Early discontinuation of antibiotics for unexplained febrile neutropenia: a pilot randomized controlled trial- EASE ANTIBIOTICS pilot trial

Principal investigatorCIHR2023Project Grant

Principal investigators: Husain, Shahid; Belga, Sara; Daneman, Nick; Dufresne, Simon F; Haider, Shariq; Kabbani, Dima; Pérez-Cortés Villalobos, Armelle; Shalhoub, Sarah; Stern, Anat

Keywords: Acute Leukemia; Allogeneic Hematopoietic Stem Cell Transplant; Antibiotic Stewardship; Febrile Neutropenia

$512,551

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Department of Medicine
Medical Microbiology and Immunology
Medicine/Cardiology
Physical Therapy
Thoracic Surgery
Other

Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.

Shahid Husain

Department of Medicine

2 shared papers, latest 2020

Heather Ross

Medicine/Cardiology

1 shared papers, latest 2018

Shaf Keshavjee

Thoracic Surgery

1 shared papers, latest 2020

Lianne Singer

Physical Therapy

1 shared papers, latest 2020

Carlos Cervera

Medical Microbiology and Immunology

1 shared papers, latest 2020

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2023

Subject: Prospective PhD student: Acute Leukemia Dear Professor Kabbani, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Granuloma in the explanted lungs: Infectious causes and impact on post-lung transplant mycobacterial infection." (2020), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Early discontinuation of antibiotics for unexplained febrile neutropenia: a pilot randomized controlled trial- EASE ANTIBIOTICS pilot trial" (2023), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]